| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.34e-05 | 188 | 108 | 7 | GO:0005201 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DSCAM SYNE1 APBB1 GAS7 CLASP2 LRRC4C ZNF365 NRP2 NEFM DACT1 MEGF9 CAPRIN2 MACF1 RAPGEF2 TNR MUC3A | 6.14e-06 | 826 | 108 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | DSCAM SYNE1 APBB1 TRIOBP CLASP2 LRRC4C ZNF365 NRP2 NEFM DACT1 MEGF9 CAPRIN2 MACF1 RAPGEF2 TNR | 8.18e-06 | 748 | 108 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection development | DSCAM SYNE1 PLA2G3 APBB1 TRIOBP GAS7 CLASP2 LRRC4C ZNF365 GSK3A NRP2 NEFM DACT1 MEGF9 CAPRIN2 CNTN3 MACF1 TBC1D23 RAPGEF2 TNR | 1.02e-05 | 1285 | 108 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | DSCAM SYNE1 APBB1 TRIOBP GAS7 CLASP2 LRRC4C ZNF365 NRP2 NEFM CCDC88C DACT1 MEGF9 CAPRIN2 MACF1 RAPGEF2 TNR MUC3A BRWD1 | 1.29e-05 | 1194 | 108 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | synapse organization | DSCAM DOK7 APBB1 CLASP2 LRRC4C ZNF365 NRP2 DACT1 GPR158 CAPRIN2 RAPGEF2 NRG3 TNR INS-IGF2 | 1.36e-05 | 685 | 108 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.43e-05 | 100 | 108 | 6 | GO:0043242 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DSCAM SYNE1 APBB1 GAS7 CLASP2 LRRC4C ZNF365 NRP2 NEFM DACT1 MEGF9 CAPRIN2 MACF1 RAPGEF2 TNR | 1.86e-05 | 802 | 108 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DSCAM SYNE1 APBB1 GAS7 CLASP2 LRRC4C ZNF365 NRP2 NEFM DACT1 MEGF9 CAPRIN2 MACF1 RAPGEF2 TNR | 2.37e-05 | 819 | 108 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell junction organization | DSCAM DOK7 APBB1 CLASP2 LRRC4C ZNF365 NRP2 DACT1 GPR158 PKP3 CAPRIN2 MACF1 RAPGEF2 NRG3 TNR INS-IGF2 | 4.63e-05 | 974 | 108 | 16 | GO:0034330 |
| GeneOntologyBiologicalProcess | neuron development | DSCAM SYNE1 PLA2G3 APBB1 TRIOBP GAS7 CLASP2 LRRC4C ZNF365 GSK3A NRP2 NEFM DACT1 MEGF9 CAPRIN2 CNTN3 MACF1 TBC1D23 RAPGEF2 TNR | 6.48e-05 | 1463 | 108 | 20 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | DSCAM SYNE1 PLA2G3 APBB1 LRRC4C ZNF365 GSK3A NEFM CAPRIN2 MACF1 RAPGEF2 TNR | 8.71e-05 | 612 | 108 | 12 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.11e-04 | 144 | 108 | 6 | GO:0043244 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | DSCAM SYNE1 ENTR1 PLA2G3 APBB1 LRRC4C ZNF365 GSK3A NEFM CAPRIN2 MACF1 RAPGEF2 TNR INS-IGF2 | 1.34e-04 | 846 | 108 | 14 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DSCAM SYNE1 ENTR1 PLA2G3 APBB1 LRRC4C ZNF365 GSK3A NEFM CAPRIN2 MACF1 RAPGEF2 TNR INS-IGF2 | 1.64e-04 | 863 | 108 | 14 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | MRE11 VTN DSCAM ARHGEF5 SYNE1 ENTR1 PLA2G3 APBB1 CLASP2 GSK3A CRACD SLF2 RAPGEF3 CAPRIN2 MACF1 RAPGEF2 CLEC16A INS-IGF2 | 2.49e-04 | 1366 | 108 | 18 | GO:0051130 |
| GeneOntologyCellularComponent | Golgi lumen | 1.11e-07 | 109 | 110 | 8 | GO:0005796 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 9.14e-05 | 17 | 110 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | extracellular matrix | VTN COL20A1 MUC5B ITIH2 OVGP1 MEGF9 MMRN2 DMBT1 TNR MUC5AC MUC6 INS-IGF2 | 1.76e-04 | 656 | 110 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | VTN COL20A1 MUC5B ITIH2 OVGP1 MEGF9 MMRN2 DMBT1 TNR MUC5AC MUC6 INS-IGF2 | 1.81e-04 | 658 | 110 | 12 | GO:0030312 |
| Domain | SEA | 8.60e-06 | 23 | 108 | 4 | PS50024 | |
| Domain | SEA_dom | 8.60e-06 | 23 | 108 | 4 | IPR000082 | |
| Domain | M_domain | 3.31e-05 | 2 | 108 | 2 | PF12938 | |
| Domain | GW182_M_dom | 3.31e-05 | 2 | 108 | 2 | IPR026805 | |
| Domain | TIL | 3.98e-05 | 12 | 108 | 3 | PF01826 | |
| Domain | C8 | 3.98e-05 | 12 | 108 | 3 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 5.16e-05 | 13 | 108 | 3 | IPR014853 | |
| Domain | C8 | 5.16e-05 | 13 | 108 | 3 | SM00832 | |
| Domain | SEA | 6.53e-05 | 14 | 108 | 3 | SM00200 | |
| Domain | TIL_dom | 6.53e-05 | 14 | 108 | 3 | IPR002919 | |
| Domain | Ago_hook | 9.90e-05 | 3 | 108 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 9.90e-05 | 3 | 108 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 9.90e-05 | 3 | 108 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 9.90e-05 | 3 | 108 | 2 | PF16608 | |
| Domain | VWD | 9.97e-05 | 16 | 108 | 3 | SM00216 | |
| Domain | VWF_type-D | 9.97e-05 | 16 | 108 | 3 | IPR001846 | |
| Domain | VWFD | 9.97e-05 | 16 | 108 | 3 | PS51233 | |
| Domain | VWD | 9.97e-05 | 16 | 108 | 3 | PF00094 | |
| Domain | VWC_out | 1.70e-04 | 19 | 108 | 3 | SM00215 | |
| Domain | SEA | 2.67e-04 | 22 | 108 | 3 | PF01390 | |
| Domain | CT | 2.67e-04 | 22 | 108 | 3 | SM00041 | |
| Domain | fn3 | 3.58e-04 | 162 | 108 | 6 | PF00041 | |
| Domain | Cys_knot_C | 3.94e-04 | 25 | 108 | 3 | IPR006207 | |
| Domain | CTCK_2 | 3.94e-04 | 25 | 108 | 3 | PS01225 | |
| Domain | WxxW_domain | 4.89e-04 | 6 | 108 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 4.89e-04 | 6 | 108 | 2 | PF13330 | |
| Domain | FN3 | 7.22e-04 | 185 | 108 | 6 | SM00060 | |
| Domain | cNMP | 9.88e-04 | 34 | 108 | 3 | SM00100 | |
| Domain | cNMP_binding | 9.88e-04 | 34 | 108 | 3 | PF00027 | |
| Domain | FN3 | 1.05e-03 | 199 | 108 | 6 | PS50853 | |
| Domain | cNMP-bd_dom | 1.08e-03 | 35 | 108 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.08e-03 | 35 | 108 | 3 | PS50042 | |
| Domain | FN3_dom | 1.36e-03 | 209 | 108 | 6 | IPR003961 | |
| Domain | cNMP-bd-like | 1.37e-03 | 38 | 108 | 3 | IPR018490 | |
| Domain | VWF_dom | 1.83e-03 | 42 | 108 | 3 | IPR001007 | |
| Domain | WW | 2.69e-03 | 48 | 108 | 3 | SM00456 | |
| Domain | - | 2.69e-03 | 48 | 108 | 3 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 3.20e-03 | 51 | 108 | 3 | IPR014710 | |
| Domain | WW_DOMAIN_2 | 3.20e-03 | 51 | 108 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 3.20e-03 | 51 | 108 | 3 | PS01159 | |
| Domain | Glyco_hormone_CN | 3.31e-03 | 15 | 108 | 2 | IPR006208 | |
| Domain | Cys_knot | 3.31e-03 | 15 | 108 | 2 | PF00007 | |
| Domain | WW_dom | 3.38e-03 | 52 | 108 | 3 | IPR001202 | |
| Domain | EGF_1 | 3.67e-03 | 255 | 108 | 6 | PS00022 | |
| Domain | EGF-like_CS | 4.10e-03 | 261 | 108 | 6 | IPR013032 | |
| Domain | EGF_2 | 4.42e-03 | 265 | 108 | 6 | PS01186 | |
| Domain | CTCK_1 | 4.77e-03 | 18 | 108 | 2 | PS01185 | |
| Domain | - | DSCAM COL20A1 LAG3 LRRC4C CMYA5 IGSF22 NFATC3 CNTN3 NCR2 TNR | 5.06e-03 | 663 | 108 | 10 | 2.60.40.10 |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.54e-10 | 16 | 76 | 6 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.37e-10 | 17 | 76 | 6 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.89e-09 | 23 | 76 | 6 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 4.24e-09 | 26 | 76 | 6 | M27483 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 8.27e-07 | 140 | 76 | 8 | M27484 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 9.72e-07 | 62 | 76 | 6 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.69e-06 | 68 | 76 | 6 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 4.35e-06 | 21 | 76 | 4 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.91e-05 | 111 | 76 | 6 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.20e-04 | 143 | 76 | 6 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 3.03e-04 | 60 | 76 | 4 | MM15636 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 4.48e-04 | 28 | 76 | 3 | M48253 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 5.92e-04 | 7 | 76 | 2 | M46421 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 9.18e-14 | 18 | 112 | 7 | 18834073 | |
| Pubmed | 1.52e-09 | 6 | 112 | 4 | 19110483 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | UBAP2 ARHGEF5 ATG13 APBB1 CBARP CLASP2 GSK3A ITPKB CCDC88C STOX2 NFATC3 SLF2 ARFGAP1 ANKRD11 RAB11FIP5 MACF1 RAPGEF2 | 2.52e-09 | 861 | 112 | 17 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 KCNH8 BICRA ATG13 TRIOBP CLASP2 TNRC6C ITPKB CFAP20DC THADA PTPRN2 GPR158 CDK13 PKP3 ANKRD11 MACF1 RAPGEF2 NRG3 GPT2 CLEC16A KDM4B | 1.09e-08 | 1489 | 112 | 21 | 28611215 |
| Pubmed | DSCAM SYNE1 PLA2G3 APBB1 TRIOBP GAS7 ZFC3H1 REV3L CMYA5 ZNF365 GSK3A NEFM MEGF9 SLF2 MACF1 TMEM131 TBC1D23 RAPGEF2 BRWD1 | 2.87e-08 | 1285 | 112 | 19 | 35914814 | |
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 3.25e-08 | 3 | 112 | 3 | 18163520 | |
| Pubmed | ATG13 SYNE1 NUP214 LRRC4C TNRC6C ZNF365 CRACD PER2 MEGF9 MACF1 CLEC16A | 8.98e-08 | 407 | 112 | 11 | 12693553 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 17471237 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 1.30e-07 | 4 | 112 | 3 | 29869461 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 23807779 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 12676567 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ATG13 ENTR1 TNRC6C CEP164 GSK3A CCDC88C IBTK NFATC3 ARFGAP1 TNRC6A TMEM131 TBC1D23 CLEC16A BRWD1 | 6.68e-07 | 853 | 112 | 14 | 28718761 |
| Pubmed | 7.23e-07 | 225 | 112 | 8 | 12168954 | ||
| Pubmed | 1.14e-06 | 104 | 112 | 6 | 9205841 | ||
| Pubmed | Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L. | 2.69e-06 | 9 | 112 | 3 | 21041412 | |
| Pubmed | UBAP2 DSCAM SYNE1 TRIOBP CLASP2 NEFM CCDC88C STOX2 PTPRN2 NFATC3 GPR158 MACF1 RAPGEF2 TNR | 2.75e-06 | 963 | 112 | 14 | 28671696 | |
| Pubmed | MRE11 BICRA ENTR1 GAS7 REV3L EZH1 ZC3H3 CACTIN THADA CAPRIN2 TNRC6A RAB11FIP5 MACF1 RAPGEF2 BRWD1 | 3.08e-06 | 1116 | 112 | 15 | 31753913 | |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 6.98e-06 | 142 | 112 | 6 | 19851296 | |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 7.27e-06 | 143 | 112 | 6 | 20198315 | |
| Pubmed | DSCAM APBB1 MUC16 CBARP CLASP2 THADA ARFGAP1 TNRC6A RAB11FIP5 RAPGEF2 CLEC16A NUP160 | 8.16e-06 | 777 | 112 | 12 | 35844135 | |
| Pubmed | 9.20e-06 | 149 | 112 | 6 | 22664934 | ||
| Pubmed | 9.48e-06 | 87 | 112 | 5 | 12465718 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 7513696 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 35533267 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 34058148 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 1.03e-05 | 2 | 112 | 2 | 14988081 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15563276 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 18782111 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12958310 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17621824 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22220206 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 24317696 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22391959 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 1.03e-05 | 2 | 112 | 2 | 35776514 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 24327612 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 1.03e-05 | 2 | 112 | 2 | 21653907 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 28321513 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 9422745 | ||
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 1.03e-05 | 2 | 112 | 2 | 36427316 | |
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 1.03e-05 | 2 | 112 | 2 | 28607090 | |
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 1.03e-05 | 2 | 112 | 2 | 10973822 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12360467 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 1.03e-05 | 2 | 112 | 2 | 23272068 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 31030254 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 1.03e-05 | 2 | 112 | 2 | 27729120 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 9334251 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 1.03e-05 | 2 | 112 | 2 | 23527003 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 16540890 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 36111525 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 1.03e-05 | 2 | 112 | 2 | 27845589 | |
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 1.03e-05 | 2 | 112 | 2 | 2393399 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11289722 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 27435107 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26871672 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11988092 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 1.03e-05 | 2 | 112 | 2 | 32348677 | |
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 1.03e-05 | 2 | 112 | 2 | 11587997 | |
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 1.03e-05 | 2 | 112 | 2 | 24722639 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 1.03e-05 | 2 | 112 | 2 | 24332705 | |
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 1.03e-05 | 2 | 112 | 2 | 10405327 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 1.03e-05 | 2 | 112 | 2 | 34656442 | |
| Pubmed | 1.87e-05 | 100 | 112 | 5 | 10048485 | ||
| Pubmed | Analysis of Expression Pattern and Genetic Deletion of Netrin5 in the Developing Mouse. | 2.14e-05 | 17 | 112 | 3 | 26858598 | |
| Pubmed | 2.16e-05 | 103 | 112 | 5 | 10819331 | ||
| Pubmed | 2.41e-05 | 263 | 112 | 7 | 34702444 | ||
| Pubmed | 2.45e-05 | 52 | 112 | 4 | 26633812 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 33232357 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 27776277 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 29286856 | ||
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 3.08e-05 | 3 | 112 | 2 | 12399109 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 27230679 | ||
| Pubmed | Mucin expression in reactive gastropathy: an immunohistochemical analysis. | 3.08e-05 | 3 | 112 | 2 | 17227128 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 36675209 | ||
| Pubmed | GSK3 activity regulates rhythms in hippocampal clock gene expression and synaptic plasticity. | 3.08e-05 | 3 | 112 | 2 | 28556462 | |
| Pubmed | Otx1 function overlaps with Otx2 in development of mouse forebrain and midbrain. | 3.08e-05 | 3 | 112 | 2 | 9077465 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 23828549 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 36672824 | ||
| Pubmed | Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development. | 3.08e-05 | 3 | 112 | 2 | 14517551 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 29802623 | ||
| Pubmed | ZNF365 promotes stalled replication forks recovery to maintain genome stability. | 3.08e-05 | 3 | 112 | 2 | 23966166 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 26770020 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 18825309 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 10512748 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 18300795 | ||
| Pubmed | Autophagy of mucin granules contributes to resolution of airway mucous metaplasia. | 3.08e-05 | 3 | 112 | 2 | 34158522 | |
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 3.08e-05 | 3 | 112 | 2 | 34108231 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 19924550 | ||
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 3.08e-05 | 3 | 112 | 2 | 29604272 | |
| Pubmed | IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. | 3.08e-05 | 3 | 112 | 2 | 19596978 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 16880270 | ||
| Pubmed | Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium. | 3.08e-05 | 3 | 112 | 2 | 19556605 | |
| Pubmed | Aquaporin 5 expression increases mucin production in lung adenocarcinoma. | 3.08e-05 | 3 | 112 | 2 | 21455588 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 31670606 | ||
| Pubmed | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. | 3.08e-05 | 3 | 112 | 2 | 20422702 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 19718741 | ||
| Pubmed | 3.25e-05 | 493 | 112 | 9 | 15368895 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.49e-05 | 120 | 112 | 5 | 31413325 | |
| Interaction | BICD1 interactions | DSCAM ENTR1 TNRC6C CEP164 GSK3A CCDC88C NFATC3 ARFGAP1 TNRC6A BRWD1 | 1.05e-06 | 250 | 109 | 10 | int:BICD1 |
| Cytoband | 11p15.5 | 1.11e-05 | 118 | 112 | 5 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 7.67e-05 | 564 | 112 | 8 | chr11p15 | |
| Cytoband | 7q22 | 1.12e-04 | 38 | 112 | 3 | 7q22 | |
| GeneFamily | CD molecules|Mucins | 7.35e-15 | 21 | 71 | 8 | 648 | |
| GeneFamily | Fibronectin type III domain containing | 3.90e-05 | 160 | 71 | 6 | 555 | |
| Coexpression | NABA_ECM_AFFILIATED | 6.20e-07 | 170 | 110 | 8 | M5880 | |
| Coexpression | NABA_MATRISOME | VTN COL20A1 MUC16 MUC5B MUC12 ITIH2 OVGP1 MEGF9 MMRN2 DMBT1 NRG3 TNR MUC3A MUC5AC MUC6 INS-IGF2 PARM1 | 1.31e-06 | 1026 | 110 | 17 | M5889 |
| Coexpression | NABA_MATRISOME | VTN COL20A1 MUC16 MUC5B ITIH2 OVGP1 MEGF9 MMRN2 DMBT1 NRG3 TNR MUC5AC MUC6 INS-IGF2 PARM1 | 2.08e-05 | 1008 | 110 | 15 | MM17056 |
| Coexpression | GSE3982_MAC_VS_NKCELL_DN | 2.08e-05 | 198 | 110 | 7 | M5509 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | 2.15e-05 | 199 | 110 | 7 | M4350 | |
| Coexpression | NABA_ECM_AFFILIATED | 5.57e-05 | 158 | 110 | 6 | MM17063 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.06e-07 | 168 | 110 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | (5)_Glands_mucous|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.04e-07 | 178 | 110 | 7 | f0f19b0d78f2cc5df4d4c321a953a6e447d5114a | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.28e-07 | 180 | 110 | 7 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.45e-07 | 199 | 110 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.20e-06 | 177 | 110 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-06 | 179 | 110 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 6.29e-06 | 183 | 110 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-06 | 184 | 110 | 6 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 8.28e-06 | 192 | 110 | 6 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 9.58e-06 | 197 | 110 | 6 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.04e-05 | 200 | 110 | 6 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 127 | 110 | 5 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-05 | 145 | 110 | 5 | bfa196ac1db7acbfcbb2ba9f137036a95e16e091 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-05 | 157 | 110 | 5 | c43f2e1ea53b375a7432f17f87cfef3b2261003d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.70e-05 | 159 | 110 | 5 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-ILC3|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.98e-05 | 161 | 110 | 5 | 584e44e6048c2678eb72cd23a86f48f2466c5da4 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.44e-05 | 164 | 110 | 5 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | Club-club-12|World / Class top | 5.60e-05 | 165 | 110 | 5 | 9b7a31cbdcd2f96b8bd08a4cd4141b92bd5e9062 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 5.93e-05 | 167 | 110 | 5 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | Tuft-tuft-1|World / Class top | 6.10e-05 | 168 | 110 | 5 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 171 | 110 | 5 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.82e-05 | 172 | 110 | 5 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-05 | 174 | 110 | 5 | 1c073177c1753e3b91ef8fd9e95230a1d13c82f3 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-05 | 174 | 110 | 5 | 5491ad5c144baf2ef9b1c58eb720c872d14feb15 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.40e-05 | 175 | 110 | 5 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.40e-05 | 175 | 110 | 5 | 19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51 | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R-_NK_cell|World / Lineage, cell class and subclass | 8.02e-05 | 178 | 110 | 5 | 0f95e2cd448a8e5eb23b29f57cf3321ff8b1a672 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 178 | 110 | 5 | 3e8aacb27ed1a3c3978e21dddddd0828f8000692 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 8.23e-05 | 179 | 110 | 5 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.23e-05 | 179 | 110 | 5 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 8.23e-05 | 179 | 110 | 5 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-05 | 179 | 110 | 5 | c7c74e26bbf86c5326ee38bac7de111d5414f46b | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.45e-05 | 180 | 110 | 5 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.45e-05 | 180 | 110 | 5 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.45e-05 | 180 | 110 | 5 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-05 | 182 | 110 | 5 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.90e-05 | 182 | 110 | 5 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.90e-05 | 182 | 110 | 5 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.90e-05 | 182 | 110 | 5 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.37e-05 | 184 | 110 | 5 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R-_NK_cell|lymphoid / Lineage, cell class and subclass | 9.37e-05 | 184 | 110 | 5 | 62a3918705a3fcf3ef25c9ceb80f575a2e56ef76 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.37e-05 | 184 | 110 | 5 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 9.37e-05 | 184 | 110 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-05 | 185 | 110 | 5 | 11c147f3f5570c4761d2bcff3bad28146b4a5861 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 185 | 110 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 185 | 110 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 186 | 110 | 5 | e3a14f3ccadbf3211822c67b8956ee01f563307a | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 186 | 110 | 5 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 186 | 110 | 5 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.86e-05 | 186 | 110 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 1.01e-04 | 187 | 110 | 5 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 188 | 110 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 110 | 5 | 7471c194276161422326647f09022e94f3d1640c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 188 | 110 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 110 | 5 | 053c251d3ddbeb866f34565aefca4535517b4387 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 189 | 110 | 5 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 189 | 110 | 5 | a618a1ddf5097a010c6c2c7341f3a0bd46a29c02 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 189 | 110 | 5 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 189 | 110 | 5 | 4e61f9cd1c06bddb47ebf98affc0f97770e26e8c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 190 | 110 | 5 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 190 | 110 | 5 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 190 | 110 | 5 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 110 | 5 | ece87127f85939e61b1048d968ed96f0e87c3a79 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 110 | 5 | 478e8341ee03b05501e2233e02cef5f97492c95d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 191 | 110 | 5 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.14e-04 | 192 | 110 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 192 | 110 | 5 | 612be3f861bd2f71a31c57f48c8b10930c3471ea | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-04 | 192 | 110 | 5 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 192 | 110 | 5 | f627a3f43e2340c8ba502211940171f25c7ff436 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-2|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.15e-04 | 101 | 110 | 4 | 0e7f4c21e1302c3e24840db3cd0f4639301d34c1 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.17e-04 | 193 | 110 | 5 | 4f38aae346ea3b4258744e9dc1e5aeb4fea13d06 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 193 | 110 | 5 | 4aee372ba2c0351b0221d0d468707d1ad21526d6 | |
| ToppCell | 10x5'-GI_small-bowel|World / Manually curated celltypes from each tissue | 1.17e-04 | 193 | 110 | 5 | cd89dfe53a114078f06343049685883c8e26508f | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 193 | 110 | 5 | aaa5042388dc451bff384c6bb237348f08280a08 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-04 | 193 | 110 | 5 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 195 | 110 | 5 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-04 | 195 | 110 | 5 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 195 | 110 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 195 | 110 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 195 | 110 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 1.26e-04 | 196 | 110 | 5 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 196 | 110 | 5 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 196 | 110 | 5 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 196 | 110 | 5 | a2db88fad9bbc55685f8e681d120ef38715ca3c4 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.29e-04 | 197 | 110 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-04 | 197 | 110 | 5 | a72047b7428c0d4aaf016c1ac23dc30919260fd8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.29e-04 | 197 | 110 | 5 | b8dc192fc98428bbb701cc2ea57fc8ad93397785 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.32e-04 | 198 | 110 | 5 | 02d0d8a212e09c0962ab1dae6a885d26d357f66a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-04 | 198 | 110 | 5 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-04 | 199 | 110 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 199 | 110 | 5 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A | SYNE1 TEDC2 PLA2G3 UBOX5 KLHL20 CACTIN SLF2 PKP3 PARM1 BRWD1 | 4.14e-08 | 197 | 110 | 10 | 7311_UP |
| Drug | rioprostil | 4.36e-07 | 32 | 110 | 5 | CID005311413 | |
| Drug | Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 4.54e-07 | 195 | 110 | 9 | 2126_UP | |
| Drug | 5155877; Down 200; 10uM; PC3; HT_HG-U133A | 5.16e-07 | 198 | 110 | 9 | 6544_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 5.16e-07 | 198 | 110 | 9 | 7233_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 4.52e-06 | 193 | 110 | 8 | 3708_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 4.52e-06 | 193 | 110 | 8 | 2283_UP | |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.69e-06 | 194 | 110 | 8 | 5932_DN | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; PC3; HT_HG-U133A | 4.87e-06 | 195 | 110 | 8 | 4232_UP | |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 5.45e-06 | 198 | 110 | 8 | 2623_UP | |
| Drug | Cromolyn disodium salt [15826-37-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.45e-06 | 198 | 110 | 8 | 3475_DN | |
| Drug | Iodipamide [606-17-7]; Up 200; 3.6uM; PC3; HT_HG-U133A | 5.66e-06 | 199 | 110 | 8 | 5085_UP | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A | 5.87e-06 | 200 | 110 | 8 | 7480_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; PC3; HT_HG-U133A | 2.66e-05 | 179 | 110 | 7 | 4619_UP | |
| Drug | cellobiitol | 3.01e-05 | 37 | 110 | 4 | CID000003871 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 3.28e-05 | 185 | 110 | 7 | 1226_UP | |
| Drug | Tetrandrine [518-34-3]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 3.28e-05 | 185 | 110 | 7 | 6082_UP | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 3.52e-05 | 187 | 110 | 7 | 6955_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; PC3; HT_HG-U133A | 3.89e-05 | 190 | 110 | 7 | 6680_DN | |
| Drug | deferoxamine mesylate salt; Up 200; 100uM; MCF7; HG-U133A | 4.16e-05 | 192 | 110 | 7 | 485_UP | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 4.16e-05 | 192 | 110 | 7 | 3236_UP | |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 4.30e-05 | 193 | 110 | 7 | 3200_DN | |
| Drug | Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.30e-05 | 193 | 110 | 7 | 6345_DN | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 4.44e-05 | 194 | 110 | 7 | 7354_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A_EA | 4.44e-05 | 194 | 110 | 7 | 1020_UP | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 2121_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; HL60; HG-U133A | 4.59e-05 | 195 | 110 | 7 | 1966_UP | |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 6650_DN | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 4779_DN | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; PC3; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 4087_UP | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 7424_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; HL60; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 1346_UP | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 6012_DN | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 6785_DN | |
| Drug | Lidoflazine [3416-26-0]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 3201_UP | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.90e-05 | 197 | 110 | 7 | 1012_DN | |
| Drug | Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 5044_DN | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; PC3; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 7274_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 5600_DN | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 6059_UP | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; PC3; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 7317_UP | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A | 5.05e-05 | 198 | 110 | 7 | 407_DN | |
| Drug | estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 1208_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; PC3; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 5087_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 6942_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; PC3; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 7281_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 5570_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 6836_DN | |
| Drug | Mifepristone [84371-65-3]; Up 200; 9.4uM; HL60; HG-U133A | 5.22e-05 | 199 | 110 | 7 | 1569_UP | |
| Drug | Stachydrine hydrochloride; Up 200; 22.2uM; PC3; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 4469_UP | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 2648_UP | |
| Drug | genistein; Up 200; 10uM; PC3; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 1235_UP | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 4837_UP | |
| Drug | Trimethadione [127-48-0]; Down 200; 28uM; PC3; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 4086_DN | |
| Drug | Gastrin tetrapeptide | 1.00e-04 | 50 | 110 | 4 | CID000005415 | |
| Drug | AC1L1GTT | 1.40e-04 | 233 | 110 | 7 | CID000003837 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.91e-04 | 172 | 110 | 6 | 6989_UP | |
| Drug | 3-isothiocyanatobutanal | 2.29e-04 | 5 | 110 | 2 | CID011355490 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.51e-04 | 181 | 110 | 6 | 1077_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.99e-04 | 187 | 110 | 6 | 1218_UP | |
| Drug | wortmannin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.17e-04 | 189 | 110 | 6 | 869_DN | |
| Drug | Lanatoside C [17575-22-3]; Down 200; 4uM; PC3; HT_HG-U133A | 3.35e-04 | 191 | 110 | 6 | 4328_DN | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.35e-04 | 191 | 110 | 6 | 4791_UP | |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 3.54e-04 | 193 | 110 | 6 | 7341_UP | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.54e-04 | 193 | 110 | 6 | 3229_DN | |
| Drug | Epitiostanol [2363-58-8]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.54e-04 | 193 | 110 | 6 | 4788_UP | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; HL60; HG-U133A | 3.54e-04 | 193 | 110 | 6 | 1547_UP | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.54e-04 | 193 | 110 | 6 | 5271_UP | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 3.54e-04 | 193 | 110 | 6 | 6946_DN | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.54e-04 | 193 | 110 | 6 | 5315_UP | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 5641_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HG-U133A | 3.64e-04 | 194 | 110 | 6 | 1924_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Down 200; 24uM; HL60; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 6156_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 2221_DN | |
| Drug | ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 1205_UP | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 4310_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 4417_DN | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; PC3; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 5826_DN | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 6660_DN | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 1675_DN | |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 4275_DN | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 1814_DN | |
| Drug | 5279552; Up 200; 22uM; MCF7; HT_HG-U133A_EA | 3.64e-04 | 194 | 110 | 6 | 843_UP | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 3.74e-04 | 195 | 110 | 6 | 6063_UP | |
| Drug | Clidinium bromide [3485-62-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.74e-04 | 195 | 110 | 6 | 3476_DN | |
| Drug | Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.74e-04 | 195 | 110 | 6 | 3454_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A | 3.74e-04 | 195 | 110 | 6 | 7362_DN | |
| Drug | H-7 dihydrochloride; Up 200; 100uM; PC3; HT_HG-U133A | 3.74e-04 | 195 | 110 | 6 | 5941_UP | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 3.74e-04 | 195 | 110 | 6 | 7504_UP | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; HL60; HT_HG-U133A | 3.74e-04 | 195 | 110 | 6 | 2468_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; ssMCF7; HG-U133A | 3.74e-04 | 195 | 110 | 6 | 524_DN | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 3.74e-04 | 195 | 110 | 6 | 2875_UP | |
| Drug | SC 19220; Up 200; 10uM; MCF7; HT_HG-U133A | 3.74e-04 | 195 | 110 | 6 | 7060_UP | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.84e-04 | 196 | 110 | 6 | 2240_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Up 200; 31uM; MCF7; HT_HG-U133A | 3.84e-04 | 196 | 110 | 6 | 5999_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 3.84e-04 | 196 | 110 | 6 | 4423_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; HL60; HG-U133A | 3.84e-04 | 196 | 110 | 6 | 1575_DN | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; PC3; HG-U133A | 3.84e-04 | 196 | 110 | 6 | 1886_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | 3.84e-04 | 196 | 110 | 6 | 3732_UP | |
| Drug | Erythromycin [114-07-8]; Up 200; 5.4uM; HL60; HG-U133A | 3.84e-04 | 196 | 110 | 6 | 2010_UP | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.20e-06 | 64 | 110 | 5 | DOID:4947 (is_marker_for) | |
| Disease | gastric ulcer (implicated_via_orthology) | 1.78e-05 | 14 | 110 | 3 | DOID:10808 (implicated_via_orthology) | |
| Disease | keratoconjunctivitis (is_marker_for) | 4.12e-05 | 3 | 110 | 2 | DOID:9368 (is_marker_for) | |
| Disease | level of peroxisome proliferator-activated receptor alpha in blood serum | 4.12e-05 | 3 | 110 | 2 | OBA_2042978 | |
| Disease | age at first sexual intercourse measurement | 9.70e-05 | 383 | 110 | 8 | EFO_0009749 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.37e-04 | 5 | 110 | 2 | DOID:3030 (is_marker_for) | |
| Disease | neuroimaging measurement | UBAP2 REV3L KLHL20 NRP2 NEFM CCDC88C DACT1 THADA TNRC6A MACF1 RAPGEF2 INS-IGF2 KDM4B | 1.77e-04 | 1069 | 110 | 13 | EFO_0004346 |
| Disease | tenascin-R measurement | 2.05e-04 | 6 | 110 | 2 | EFO_0803139 | |
| Disease | muellerian-inhibiting factor measurement | 2.05e-04 | 6 | 110 | 2 | EFO_0020584 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 3.80e-04 | 8 | 110 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 3.80e-04 | 8 | 110 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 3.80e-04 | 8 | 110 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 3.80e-04 | 8 | 110 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 3.80e-04 | 8 | 110 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 3.80e-04 | 8 | 110 | 2 | C0393703 | |
| Disease | Myoclonic Epilepsy | 4.87e-04 | 9 | 110 | 2 | C0014550 | |
| Disease | urate measurement, bone density | 5.26e-04 | 619 | 110 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | Epilepsy, Myoclonic, Infantile | 6.08e-04 | 10 | 110 | 2 | C0917800 | |
| Disease | dry eye syndrome (is_marker_for) | 6.08e-04 | 10 | 110 | 2 | DOID:10140 (is_marker_for) | |
| Disease | Hypermetropia | 6.09e-04 | 103 | 110 | 4 | HP_0000540 | |
| Disease | pulmonary fibrosis | 7.41e-04 | 11 | 110 | 2 | EFO_0009448 | |
| Disease | nucleus accumbens volume change measurement | 7.41e-04 | 11 | 110 | 2 | EFO_0021493 | |
| Disease | Myoclonic Astatic Epilepsy | 7.41e-04 | 11 | 110 | 2 | C0393702 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | KIRREL3-AS3 LRRC4C REV3L OTX1 PTPRN2 TNRC6A CNTN3 NRG3 KDM4B BRWD1 | 8.39e-04 | 801 | 110 | 10 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | age of onset of multiple sclerosis | 8.87e-04 | 12 | 110 | 2 | OBA_2001029 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.05e-03 | 13 | 110 | 2 | C0751122 | |
| Disease | verbal-numerical reasoning measurement | 1.49e-03 | 131 | 110 | 4 | EFO_0008394 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.55e-03 | 61 | 110 | 3 | DOID:3587 (is_marker_for) | |
| Disease | coronary thrombosis, GM11992 | 1.60e-03 | 16 | 110 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | age at menarche | 1.75e-03 | 594 | 110 | 8 | EFO_0004703 | |
| Disease | behavior or behavioral disorder measurement, personality trait | 2.03e-03 | 18 | 110 | 2 | EFO_0004365, EFO_0004782 | |
| Disease | interstitial lung disease | 2.03e-03 | 67 | 110 | 3 | EFO_0004244 | |
| Disease | hippocampal tail volume | 2.26e-03 | 19 | 110 | 2 | EFO_0009398 | |
| Disease | anorectal malformation | 2.26e-03 | 19 | 110 | 2 | MONDO_0019938 | |
| Disease | calcium measurement | 2.47e-03 | 628 | 110 | 8 | EFO_0004838 | |
| Disease | cortical thickness | TRIOBP GAS7 NRP2 DACT1 THADA MEGF9 TNRC6A MACF1 TMEM131 INS-IGF2 KDM4B | 2.97e-03 | 1113 | 110 | 11 | EFO_0004840 |
| Disease | blood pressure | 3.03e-03 | 22 | 110 | 2 | EFO_0004325 | |
| Disease | Sjogren's syndrome (is_marker_for) | 3.60e-03 | 24 | 110 | 2 | DOID:12894 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TPSSWGRSQSSAAAE | 16 | Q8TD30 | |
| TTTATVALTTSWDNA | 16 | Q8N350 | |
| SSSSPTGSDWFNLAI | 41 | O75143 | |
| SPAWSEVSSLSDSTR | 556 | Q6UB99 | |
| TSWPPATARSTESFT | 896 | Q12774 | |
| RKSPSSDSWTCADTS | 341 | Q8N6T3 | |
| LESVLSSSSREQWTP | 566 | O00213 | |
| LTWVTSSLNPSSRDE | 71 | Q9NUG4 | |
| DVSPSPYSSSSWRRS | 381 | Q14004 | |
| STSASTLWRATNNSS | 126 | Q5SZJ8 | |
| TLWRATNNSSPDSFA | 131 | Q5SZJ8 | |
| PSSSLGTTWTRLSQT | 2541 | Q9HC84 | |
| PSSSLGTTWTRLSQT | 4526 | Q9HC84 | |
| TWPRGSRSNSSSEAV | 386 | Q9BXF6 | |
| QSATSATSSNALWEV | 271 | Q14573 | |
| TSASGASRSWVTQTL | 131 | Q8N7Y1 | |
| SARSSASSWSEEPVQ | 706 | Q92932 | |
| SEALSSTSRLWSPAA | 66 | Q7L1V2 | |
| SDSLSSISIPLNSWS | 256 | Q8N7Z5 | |
| SWTLSPFQDAASSSS | 241 | P56975 | |
| TTTWPSTSLSEALSS | 2061 | Q8WXI7 | |
| TFTLDTSSRASWPGT | 8801 | Q8WXI7 | |
| TSSRASWPGTHSAAT | 8806 | Q8WXI7 | |
| ATASSSFISSSSWLP | 2081 | Q6W4X9 | |
| SFISSSSWLPQNSSS | 2086 | Q6W4X9 | |
| AWSGSVSISSSPSDS | 161 | Q8N6Y1 | |
| NSPVWSRKSSTFDSI | 171 | P13349 | |
| SDSQTVRASPDSWLT | 551 | Q6NUN7 | |
| TQTSWTPRDLVSSQT | 136 | O95944 | |
| SSTFSLSWSDTAQVT | 786 | P19823 | |
| RSCSPSSSVSRAWDS | 31 | Q96S65 | |
| LQSRSSSLFSPWRST | 436 | Q9HC44 | |
| SSLTENWSSRQAVSS | 71 | P60608 | |
| RASASDSSAPWSRST | 51 | Q5T848 | |
| SNRIDTTSSASWVAG | 1096 | Q9P2D0 | |
| WAQASSTSLSDLQSS | 21 | Q9H8L6 | |
| WPSELGSRTCSTSAT | 1511 | Q9P219 | |
| LNATAWSPSDTSQSS | 826 | O15055 | |
| FTSTRLPTSETWLSN | 2861 | Q02505 | |
| LTPSAWEASSLRSSR | 381 | P34995 | |
| RTTWASSSSPNDRTF | 666 | O60462 | |
| TSPELSSWSASRASL | 351 | O94953 | |
| ESRFSSATWPRATKS | 251 | O94854 | |
| STSENSTSALADVSW | 496 | Q9H1U4 | |
| TSLWSLSSAVPSQSS | 891 | P35658 | |
| VWSSLDTPSQRSFSG | 381 | P18627 | |
| RASTSLTSVSWITPN | 376 | Q9HCJ2 | |
| SGRATSPTQSTSSWQ | 4071 | P98088 | |
| IWTSSPQNTDADTAS | 41 | Q6UWI2 | |
| SSLSTPAASSIWSPA | 166 | P32242 | |
| SDSSNSSISLAWREP | 811 | Q8N9C0 | |
| TSSDWQSTDATPTLT | 466 | P49840 | |
| QWSSDVAPTSTCRTS | 391 | Q9Y2M5 | |
| TDSSLPSPSSLWSAS | 316 | Q9NYF0 | |
| SQVTSSSIRLSWTPA | 386 | Q9P218 | |
| SLPSWALSDTDSRVS | 226 | Q96C92 | |
| SGITWETNSSRSSTP | 81 | Q8N3K9 | |
| ETNSSRSSTPWASEE | 86 | Q8N3K9 | |
| RSSTPWASEESQTSG | 91 | Q8N3K9 | |
| QESPSSASALAEWAS | 656 | Q6ZU35 | |
| WSRSSRPSSVDSQDL | 61 | Q6UXB0 | |
| SWRELSSGNESSSSV | 811 | Q9NSI6 | |
| NSRAGWSDSSQVSSP | 936 | Q6IMN6 | |
| SPLLASQSWSSRSMS | 746 | Q9Y4F3 | |
| ARSWSPSSSASSSAS | 106 | Q8WUQ7 | |
| PGTSWTTRSQLANTE | 36 | Q9Y5L2 | |
| SASSRLTAWPEQSSS | 276 | Q18PE1 | |
| LTAWPEQSSSSASTS | 281 | Q18PE1 | |
| SPSVTWARASSSLSS | 1256 | Q9NZM4 | |
| WPTSHASTAGSESSL | 1106 | Q9UGM3 | |
| DTWPTSRASTAGSES | 1491 | Q9UGM3 | |
| ANSLSSSEIEVSWNT | 811 | Q9P232 | |
| LQASALSLSSSTSTW | 61 | F8WCM5 | |
| WLSSAVNSSSTDPER | 396 | Q12889 | |
| SPDSSDVWRGTSIAS | 296 | Q5XKR4 | |
| TTSGTSSRLEASWLQ | 566 | Q86XP0 | |
| TSTRLPTSETWLSNN | 776 | Q9H195 | |
| ASSASSTREGQSWQP | 1951 | O60469 | |
| TTSQDWGTPRELTFS | 51 | O75298 | |
| SASSSRVSWNTPQCR | 86 | O94941 | |
| SSRQWDPASCTSLGT | 186 | Q5JUK2 | |
| ASWTNSAIQVLESSS | 361 | Q6YHU6 | |
| PTSSWQSSSASSQPR | 1601 | Q9HCJ0 | |
| GSLTRSATSWTSEAQ | 36 | Q9GZN6 | |
| SSPELNDSSVALSSW | 1546 | Q8WUY3 | |
| DVSSSQQDLSSWSSA | 8661 | Q8NF91 | |
| LWAQLSSTQTSDSTD | 221 | Q7L2K0 | |
| SGSSSPRWSTDLQSR | 461 | Q8IYG6 | |
| QSAESSDSLSWSRLP | 401 | P27987 | |
| VNTTTNETTWERPSS | 96 | O60861 | |
| RSSVSSSWNAASLLQ | 6 | Q6UWI4 | |
| SRKRSSSDSWEPTSA | 311 | Q8IX21 | |
| FPTTSKTDQRWSSTS | 656 | P49959 | |
| SPNSTASTAWLSSDG | 211 | Q12769 | |
| ASWSSRATSPTPSSR | 281 | Q9NZ20 | |
| RASSTQWNTPRASSP | 331 | Q9H2D6 | |
| NVSISTSSDDTTTWN | 581 | Q6ZVT6 | |
| FSALSSATPTSTQWA | 1321 | Q9UPV0 | |
| SAAATCSESTQWSRP | 466 | Q2KHT3 | |
| SSQESLNRPFSSKWS | 326 | O75122 | |
| PASWSSRSAVDLSCS | 116 | Q9Y446 | |
| SLEQAQSRASWASST | 1316 | Q9Y4G8 | |
| SEQSLSTRSPASTWA | 886 | O95398 | |
| QNSTSHPTTTTSWDL | 396 | Q5T6F2 | |
| ASSPSASSSSSFRWQ | 381 | Q8IXZ2 | |
| TTDSASWIRSGTLSP | 1711 | O60673 | |
| STTLRRAWPSSDFSD | 6 | Q9P2F5 | |
| NGSAWARSTTTRDSP | 1231 | O94964 | |
| WIASTSGSRSSINSV | 456 | Q9NUY8 | |
| TTPFSSSIWSSNLSS | 1801 | Q92545 | |
| SSIWSSNLSSALPFT | 1806 | Q92545 | |
| WASSSSEANSRCQTP | 396 | Q92800 | |
| AAQDTTWSSITSTAF | 1111 | Q92752 | |
| PASSISSRSWFSDAS | 166 | Q12968 | |
| FSNESPTSRETSESW | 16 | Q6ZS52 | |
| GNSSDLETTSSASPW | 81 | Q70YC4 | |
| SAFTTSDNLSLSSWV | 336 | Q9UMR3 | |
| WPITSASTENSFSTL | 1076 | Q5SVZ6 | |
| PSRATWLSLFSSEES | 396 | P04004 | |
| SSSLSESSPRPSFWE | 121 | O60293 | |
| SSLNTTLPSTSAWSS | 1661 | Q8NDV7 | |
| TLPSTSAWSSIRASN | 1666 | Q8NDV7 | |
| STSARNSDSKLTWSP | 1691 | Q8NDV7 | |
| CPSRESLQTRTSWSA | 916 | Q96L42 | |
| ESTTFQSWPSSSDTT | 3136 | Q9UKN1 | |
| RSQSWSRGSPSTVSS | 36 | P07197 |